A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

May 31, 2016

Conditions
Acute Stroke
Interventions
DRUG

IV rt-PA

open-label

Trial Locations (14)

20892

NIH/ NINDS, Washington Hospital, Suburban Hospital, Bethesda

38105

University of Tennessee Health Science Center, Memphis

52242

University of Iowa, Iowa City

60612

Rush University Medical Center, Chicago

63110

Washington University School of Medicine/Barnes Jewish Hospital, St Louis

78701

Seton/UT Southwestern Medical Center, Austin

84107

Intermountain Healthcare, Murray

85724

University of Arizona, Tucson

90048

Cedars Sinai Medical Center, Los Angeles

90095

Ronald Reagan UCLA Medical Center, Los Angeles

02114

Massachusetts General Hospital, Boston

02118

Boston Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01655

University of Massachusetts, Worcester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Genentech, Inc.

INDUSTRY

lead

Lee Schwamm

OTHER